CTO Lars Nieba has taken over as interim CEO at Nordic Nanovectors after Eduardo Bravo’s sudden departure.
ADVERTISEMENT
She was already serving as interim CEO since Nouscom founder Alfredo Nicosia retired in May 2019. Now, Marina Udiers appointment at the Basel-based immuno-oncology company has been made permanent.
Co-founder Fiona Withey is the new Chief Executive Officer of TrakCel, a software developer of orchestration systems for advanced therapies. Co-founder Ravi Nalliah was appointed to the role of Chief Strategy Officer.
Applied Photophysics Limited, active in biophysical characterization of biomolecules, has appointed Tim Flanagan as Chief Executive Officer and member of the Board of Directors.
Ex-Sandoz Head of Global Franchises Rex Clements is taking over as CEO of Centrient Pharmaceuticals. Erstwhile Centrient CEO Karl Rotthier has decided to step down, the company said.
European venture capital firm Sofinnova Partners announced the promotion of Michael Krel to Partner of the Industrial Biotechnology team. Krel previously served as Principal on the team, where he focused on early-stage deals in Europe and North America.
Ipsen has named steven Hildemann as Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance, effective March 2020.
Karl Naegler, who has been a partner at the investment company Gimv since 2011, has joined the competition. He is now Managing Partner at leading European venture capital firm Wellington Partners.
Norwegian biopharma company Zelluna Immunotherapy appointed erstwhile CSO Namir Hassan as Chief Executive Officer.
Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, has named Line Stigen Raquet as Chief Executive Officer.